Show simple item record

AuthorBouammali, Haytham
AuthorKhibech, Oussama
AuthorFraj, Elmehdi
AuthorElbouzidi, Amine
AuthorBekkouch, Ayoub
AuthorBourhou, Chaymae
AuthorZughaier, Susu M.
AuthorMerzouki, Mohammed
AuthorHassiba, Maryam
Authorjaouani, Hanane
AuthorBouammali, Boufelja
AuthorChallioui, Allal
AuthorTouzani, Rachid
Available date2026-01-28T07:29:25Z
Publication Date2026-03-01
Publication NameJournal of Ethnopharmacology
Identifierhttp://dx.doi.org/10.1016/j.jep.2025.120982
CitationBouammali, Haytham, Oussama Khibech, Elmehdi Fraj, Amine Elbouzidi, Ayoub Bekkouch, Chaymae Bourhou, Susu M. Zughaier et al. "Dual COX/5-LOX Inhibition by Isorhamnetin-3-O-Glucoside from Anthyllis cytisoides: An Integrated Chemical-Enzymatic-Computational Study." Journal of Ethnopharmacology (2025): 120982.
ISSN03788741
URIhttps://www.sciencedirect.com/science/article/pii/S0378874125016745
URIhttp://hdl.handle.net/10576/69534
AbstractEthnopharmacological relevanceAnthyllis cytisoides L. is a forage shrub native to the western Mediterranean basin, traditionally used in folk medicine to treat respiratory and gastrointestinal inflammation. However, its polar phytochemical profile and the underlying enzyme-level anti-inflammatory mechanisms involving COX-1/COX-2 and 5-LOX remain weakly documented. Aim of the studyTo integrate chemical, enzymatic, and computational evidence that links the constituents of A. cytisoides L to COX-1, COX-2, and 5-LOX targets, thereby contextualizing the species’ ethnopharmacological indications. Materials and methodsThe aerial parts were subjected to polarity-guided fractionation followed by LC–HRMS profiling. From the methanolic fraction, a flavonol glycoside was isolated and structurally elucidated as isorhamnetin-3-O-glucoside (I3OG) using ESI–MS, IR spectroscopy, and 1D/2D NMR analyses. Enzymatic inhibition of COX-1, COX-2, and 5-LOX was assessed (COX via PGE2 radioimmunoassay; 5-LOX via FOX assay at 560 nm), and IC50 values were calculated using four-parameter logistic regression (95 % CI). Molecular docking (COX-1: 1EQG; COX-2: 5F19; 5-LOX: 6NCF) and 100-ns molecular dynamics simulations (GROMACS) were also performed. ResultsI3OG was successfully identified and purified from A. cytisoides. It inhibited COX-1, COX-2, and 5-LOX with IC50 values of 10.65 ± 1.02, 15.09 ± 0.84, and 15.24 ± 1.18 μg/mL (≈22.3, 31.6, and 31.9 μM), respectively, surpassing the inhibitory activity of the crude extracts for all targets. Docking studies and 100-ns MD simulations confirmed stable interactions with each enzyme, in agreement with the experimental inhibition ranking (COX-1 > COX-2 ≈ 5-LOX). ConclusionI3OG emerges as a promising dual COX/5-LOX candidate from A. cytisoides, providing a coherent link between detailed phytochemical analysis, enzymatic inhibition, and atomistic binding mechanisms. Although selectivity and safety considerations fall outside the scope of this enzyme-focused study, the findings highlight A. cytisoides as a valuable source of multitarget anti-inflammatory scaffolds and support SAR-driven optimization and formulation strategies aimed at enhancing bioactivity.
Languageen
PublisherElsevier
SubjectAnthyllis cytisoides L.
I3OG
COX/5-LOX inhibition
LC-HRMS
Molecular docking & MD
TitleDual COX/5-LOX inhibition by isorhamnetin-3-O-glucoside from Anthyllis cytisoides: An integrated chemical-enzymatic-computational study
TypeArticle
Volume Number358
ESSN1872-7573
dc.accessType Full Text


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record